Dextrose Injection Market to Surpass US$ 14,056.6 Million by 2027 coherentmarketinsights.com
Dextrose injection contain source of water and calories, and is capable of inducing diuresis depending on the clinical condition of the patient. Dextrose injections are sterile, non-pyrogenic, and does not contain bacteriostatic or antimicrobial agents. It is intended for intravenous administration.
Report Story